Sinopharm Group Co. Ltd. (SHTDY)
USD 11.35
(1.25%)
USD 11.35
(1.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 60.02 Billion CNY | -1.47% |
| 2022 | 60.92 Billion CNY | 18.3% |
| 2021 | 51.49 Billion CNY | 9.37% |
| 2020 | 47.08 Billion CNY | 10.54% |
| 2019 | 42.59 Billion CNY | 20.36% |
| 2018 | 35.38 Billion CNY | 32.2% |
| 2017 | 26.76 Billion CNY | 3.92% |
| 2016 | 25.75 Billion CNY | 15.26% |
| 2015 | 22.34 Billion CNY | 10.05% |
| 2014 | 20.3 Billion CNY | 21.59% |
| 2013 | 16.7 Billion CNY | 22.65% |
| 2012 | 13.61 Billion CNY | 11.49% |
| 2011 | 12.21 Billion CNY | 62.2% |
| 2010 | 7.53 Billion CNY | 76.24% |
| 2009 | 4.27 Billion CNY | 35.44% |
| 2008 | 3.15 Billion CNY | 19.76% |
| 2007 | 2.63 Billion CNY | 28.92% |
| 2006 | 2.04 Billion CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 68.83 Billion CNY | 6.58% |
| 2024 Q1 | 64.58 Billion CNY | 7.6% |
| 2023 Q3 | 66.29 Billion CNY | -0.94% |
| 2023 FY | 60.02 Billion CNY | -1.47% |
| 2023 Q4 | 60.02 Billion CNY | -9.45% |
| 2023 Q2 | 66.92 Billion CNY | -0.6% |
| 2023 Q1 | 67.32 Billion CNY | 10.5% |
| 2022 Q2 | 56.99 Billion CNY | 1.23% |
| 2022 FY | 60.92 Billion CNY | 18.3% |
| 2022 Q3 | 59.28 Billion CNY | 4.02% |
| 2022 Q4 | 60.92 Billion CNY | 2.77% |
| 2022 Q1 | 56.3 Billion CNY | 9.33% |
| 2021 Q4 | 51.49 Billion CNY | -1.09% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q3 | 52.06 Billion CNY | 2.45% |
| 2021 FY | 51.49 Billion CNY | 9.37% |
| 2021 Q2 | 50.81 Billion CNY | 0.0% |
| 2020 Q3 | 48.74 Billion CNY | 4.41% |
| 2020 Q2 | 46.68 Billion CNY | -4.55% |
| 2020 Q1 | 48.91 Billion CNY | 14.84% |
| 2020 FY | 47.08 Billion CNY | 10.54% |
| 2020 Q4 | 47.08 Billion CNY | -3.41% |
| 2019 Q1 | 39.75 Billion CNY | 12.34% |
| 2019 Q2 | 40.99 Billion CNY | 3.12% |
| 2019 Q3 | 45.47 Billion CNY | 10.93% |
| 2019 Q4 | 42.59 Billion CNY | -6.34% |
| 2019 FY | 42.59 Billion CNY | 20.36% |
| 2018 Q2 | 27.35 Billion CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 FY | 35.38 Billion CNY | 32.2% |
| 2018 Q4 | 35.38 Billion CNY | 0.0% |
| 2017 Q3 | 30.27 Billion CNY | 24.39% |
| 2017 Q4 | 26.76 Billion CNY | -11.58% |
| 2017 FY | 26.76 Billion CNY | 3.92% |
| 2017 Q2 | 24.33 Billion CNY | 0.0% |
| 2017 Q1 | 24.33 Billion CNY | -5.52% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 25.75 Billion CNY | 0.0% |
| 2016 Q3 | 25.75 Billion CNY | 15.04% |
| 2016 Q2 | 22.39 Billion CNY | 0.0% |
| 2016 FY | 25.75 Billion CNY | 15.26% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 22.34 Billion CNY | 10.05% |
| 2015 Q3 | 22.55 Billion CNY | 13.27% |
| 2015 Q2 | 19.91 Billion CNY | 0.0% |
| 2015 Q4 | 22.34 Billion CNY | -0.91% |
| 2014 Q1 | 17.04 Billion CNY | 2.05% |
| 2014 Q4 | 20.3 Billion CNY | 0.0% |
| 2014 FY | 20.3 Billion CNY | 21.59% |
| 2014 Q3 | 20.3 Billion CNY | 19.15% |
| 2014 Q2 | 17.04 Billion CNY | 0.0% |
| 2013 Q2 | 14.44 Billion CNY | 0.0% |
| 2013 Q1 | 14.44 Billion CNY | 6.09% |
| 2013 FY | 16.7 Billion CNY | 22.65% |
| 2013 Q4 | 16.7 Billion CNY | 0.0% |
| 2013 Q3 | 16.7 Billion CNY | 15.6% |
| 2012 FY | 13.61 Billion CNY | 11.49% |
| 2012 Q2 | 11.48 Billion CNY | 0.0% |
| 2012 Q4 | 13.61 Billion CNY | 0.0% |
| 2011 FY | 12.21 Billion CNY | 62.2% |
| 2011 Q4 | 12.21 Billion CNY | 0.0% |
| 2011 Q2 | 8.88 Billion CNY | 0.0% |
| 2010 FY | 7.53 Billion CNY | 76.24% |
| 2010 Q4 | 7.53 Billion CNY | 0.0% |
| 2010 Q2 | 5.3 Billion CNY | 0.0% |
| 2009 FY | 4.27 Billion CNY | 35.44% |
| 2009 Q4 | 4.27 Billion CNY | 0.0% |
| 2009 Q2 | 3.44 Billion CNY | 0.0% |
| 2008 Q4 | 3.15 Billion CNY | 0.0% |
| 2008 FY | 3.15 Billion CNY | 19.76% |
| 2007 FY | 2.63 Billion CNY | 28.92% |
| 2006 FY | 2.04 Billion CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| China Medicine Corporation | 2.73 Million USD | -2197831.747% |
| DH Enchantment Inc. | 613.00 USD | -9792438399.184% |
| Exlites Holdings International, Inc. | - USD | -Infinity% |
| Itonis, Inc. | - USD | -Infinity% |
| One Step Vending Corp. | 2655.00 USD | -2260928261.582% |
| MediPal Holdings Corporation | 1.13 Billion USD | -5181.324% |
| PD-Rx Pharmaceuticals, Inc. | 1.64 Million USD | -3659285.689% |
| Pharmagen, Inc. | 136.97 USD | -43825398162.393% |
| Suzuken Co., Ltd. | 940.54 Million USD | -6282.212% |